Literature DB >> 18946102

Placenta accreta: an association with fibroids and Asherman syndrome.

Amal Al-Serehi1, Anna Mhoyan, Michelle Brown, Kurt Benirschke, Andrew Hull, Dolores H Pretorius.   

Abstract

OBJECTIVE: Placenta accreta is a life-threatening problem that is rising in incidence in the developed world. The increased risk of placenta accreta in women with placenta previa and 1 or more prior cesarean deliveries is well established and prompts careful sonographic evaluation. Our objective was to emphasize that accreta is also identified at sites other than cesarean scars.
METHODS: Two cases of placenta accreta without placenta previa seen in association with uterine scarring from myomectomy and uterine fibroids are described.
RESULTS: The sonographic and magnetic resonance imaging findings of accreta are reviewed in the classic setting of prior cesarean deliveries as well as myomectomy and uterine fibroids.
CONCLUSIONS: We suggest that when the placenta overlies any uterine abnormality, a careful search for invasive placentation is warranted.

Entities:  

Mesh:

Year:  2008        PMID: 18946102     DOI: 10.7863/jum.2008.27.11.1623

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  10 in total

Review 1.  [Histopathology and clinical aspects of extrauterine pregnancy].

Authors:  L-C Horn; S Opitz; R Handzel; C E Brambs
Journal:  Pathologe       Date:  2018-09       Impact factor: 1.011

2.  Maternal serum markers, characteristics and morbidly adherent placenta in women with previa.

Authors:  D J Lyell; A M Faucett; R J Baer; Y J Blumenfeld; M L Druzin; Y Y El-Sayed; G M Shaw; R J Currier; L L Jelliffe-Pawlowski
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

3.  Value of ultrasound scoring system for assessing risk of pernicious placenta previa with accreta spectrum disorders and poor pregnancy outcomes.

Authors:  Lingling Zhu; Limei Xie
Journal:  J Med Ultrason (2001)       Date:  2019-08-07       Impact factor: 1.314

4.  Placenta Percreta Presenting with Delayed Haematuria.

Authors:  Vinayak Gorakhanath Wagaskar; Sudarshan Omprakash Daga; Sujata Kiran Patwardhan
Journal:  J Clin Diagn Res       Date:  2015-12-01

5.  Placenta accreta following hysteroscopic myomectomy.

Authors:  Mie Tanaka; Shinya Matsuzaki; Satoko Matsuzaki; Aiko Kakigano; Keiichi Kumasawa; Yutaka Ueda; Masayuki Endo; Tadashi Kimura
Journal:  Clin Case Rep       Date:  2016-04-20

6.  Does hysteroscopic metroplasty for septate uterus represent a risk factor for adverse outcome during pregnancy and labor?

Authors:  Nataša Kenda Šuster; Marco Gergolet
Journal:  Gynecol Surg       Date:  2015-10-31

7.  The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: A case-control study.

Authors:  Saeed Baradwan; Afnan Baradwan; Muhammad Bashir; Dania Al-Jaroudi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

8.  Impact of prolonged one or more natural menstrual cycles on the outcomes of ovulation induction intrauterine artificial insemination pregnancy: a single-centre, retrospective study in China.

Authors:  Shuai Zhang; Han-Han Tang; Ming-Lian Zhou
Journal:  BMJ Open       Date:  2022-06-20       Impact factor: 3.006

9.  Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study.

Authors:  Kathryn E Fitzpatrick; Susan Sellers; Patsy Spark; Jennifer J Kurinczuk; Peter Brocklehurst; Marian Knight
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: a case-control study.

Authors:  Cynthia M Farquhar; Zhuoyang Li; Sarah Lensen; Claire McLintock; Wendy Pollock; Michael J Peek; David Ellwood; Marian Knight; Caroline Se Homer; Geraldine Vaughan; Alex Wang; Elizabeth Sullivan
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.